Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.

Alendronate (ALN), an aminobisphosphonate used in the treatment of osteoporosis, is a potent inhibitor of bone resorption. Its molecular target is still unknown. This study examines the effects of ALN on the activity of osteoclast protein-tyrosine phosphatase (PTP; protein-tyrosine-phosphate phospho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schmidt, A, Rutledge, S J, Endo, N, Opas, E E, Tanaka, H, Wesolowski, G, Leu, C T, Huang, Z, Ramachandaran, C, Rodan, S B, Rodan, G A
Formato: Artigo
Idioma:Inglês
Publicado em: 1996
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC39762/
https://ncbi.nlm.nih.gov/pubmed/8610169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados